/
CNBX
$0.00-$0.00 (-50.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.01
0% from low
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change$-9.42
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.6K | $9.8K | $7.2K | $0 | $30.0K | $410.2K | $130.1K | $0 |
| Cost of revenue | $0 | $0 | $0 | $220.9K | $198.5K | $0 | $0 | $0 |
| Gross profit | $9.6K | $9.8K | $7.2K | −$221.0K | −$169.0K | $410.2K | $130.1K | $0 |
| Gross margin | 100.0% | 100.0% | 100.0% | — | -564.1% | 100.0% | 100.0% | — |
| R&D | $1.0M | $1.5M | $1.7M | $1.8M | $1.2M | $431.6K | $194.8K | $0 |
| Operating income | −$3.8M | −$3.3M | −$3.0M | −$2.6M | −$3.0M | −$931.0K | −$583.0K | −$271.7K |
| EBITDA | −$3.7M | $1.3M | −$7.2M | −$2.9M | −$3.5M | −$3.5M | −$603.0K | −$273.8K |
| Net income | −$3.8M | $1.1M | −$7.5M | −$3.2M | −$3.7M | −$3.7M | −$695.0K | −$314.0K |
| Net margin | -39335.7% | 11510.7% | -104331.4% | — | -12427.4% | -904.5% | -534.3% | — |
| EPS (diluted) | -3.72 | 1.03 | -12.00 | -2.16 | -3.59 | -0.42 | -0.02 | -0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
CNBX PHARMACEUTICAL INC
CNBX PHARMACEUTICAL INC
Held by traders on TradeandTell
No one on the platform currently holds CNBX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CNBX as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2022-05-12 | 1-for-120reverse |
| 2014-06-30 | 2-for-1 |
| 2010-09-30 | 1-for-20reverse |
Recent trades on TradeandTell
No one on the platform has traded CNBX yet.
